1例免疫检查点抑制剂相关暴发性心肌炎患者的护理

doi:10.3761/j.issn.0254-1769.2022.14.012

摘要/Abstract

摘要：

心肌炎是免疫检查点抑制剂相关的高致死率免疫不良反应,其诊断、治疗及护理均较为复杂。该文总结1例低分化肺腺癌患者应用免疫检查点抑制剂并发暴发性心肌炎患者的护理,护理要点包括病情监测与预评估、体外膜肺氧合支持的护理、降低感染加重风险、并发症的预防与护理、康复指导和健康教育。经过25 d的积极治疗和精心护理,患者病情好转并顺利出院,电话随访6个月,状况良好。

关键词: 免疫检查点抑制剂, 暴发性心肌炎, 体外膜肺氧合, 护理

Abstract:

Myocarditis is a highly lethal immune adverse reaction associated with immune checkpoint inhibitors （ICIs）,and its diagnosis,treatment and nursing are complicated. This paper summarizes the nursing care of a patient with low-differentiated lung adenocarcinoma complicated with fulminant myocarditis who was treated with ICIs. The key points of nursing care include：monitoring and pre-evaluation of the condition,nursing care supported by ECMO,reducing the risk of infection aggravation,prevention and nursing care of complications,rehabilitation guidance and disease education. After 25 days of active treatment and careful nursing care,the patient’s condition improved and he was discharged smoothly. Telephone follow-up for 6 months showed good condition.

Key words: Immune Checkpoint Inhibitors, Fulminant Myocarditis, Extracorporeal Membrane Oxygenation, Nursing Care

邱小英, 石泽亚, 张艳, 李利花, 吴娟. 1例免疫检查点抑制剂相关暴发性心肌炎患者的护理[J]. 中华护理杂志, 2022, 57(14): 1744-1748.

QIU Xiaoying, SHI Zeya, ZHANG Yan, LI Lihua, WU Juan. Nursing care of a patient with immune checkpoint inhibitor-associated fulminant myocarditis[J]. Chinese Journal of Nursing, 2022, 57(14): 1744-1748.

参考文献 18

[1]	Wang F, Qin S. Progress in diagnosis and treatment of immune checkpoint inhibitor-associated cardiotoxicity[J]. J Cancer Immu-nol, 2020, 2(3):96-102.
[2]	中国抗癌协会整合肿瘤心脏病学分会, 中华医学会心血管病学分会肿瘤心脏病学学组, 中国医师协会心血管内科医师分会肿瘤心脏病学专业委员会, 等. 免疫检查点抑制剂相关心肌炎监测与管理中国专家共识(2020版)[J]. 中国肿瘤临床, 2020, 47(20):1027-1038.
	Society of Integrative Cardio-Oncology China Anti-Cancer Association,the Cardio-Oncology Group of the Chinese Society of Cardiovascular Diseases of Chinese Medical Association, Chinese College of Cardiovascular Physicians Specialized Committee on Cardio-Oncology Chinese Medical Doctor Association, et al. Chinese expert consensus on the surveillance and management of immune checkpoint inhibitor-related myocarditis(2020 version)[J]. Chin J Clin Oncol, 2020, 47(20):1027-1038.
[3]	刘运炜, 陈燕欣, 曾治民, 等. 免疫检查点抑制剂相关心肌炎的研究进展[J]. 中国肺癌杂志, 2021, 24(9):668-672.
	Liu YW, Chen YX, Zeng ZM, et al. Research progress of immune checkpoint inhibitor-associated myocarditis[J]. Chin J Lung Cancer, 2021, 24(9):668-672.
[4]	王涟, 王振伟, 魏钟海, 等. 免疫检查点抑制剂相关暴发性心肌炎救治一例[J]. 中华心力衰竭和心肌病杂志, 2020, 4(2):125-127.
	Wang L, Wang ZW, Wei ZH, et al. Treatment of fulminant myocarditis with immune checkpoint inhibitors:a case study[J]. Chin J Heart Failure Cardiomyopathy, 2020, 4(2):125-127.
[5]	Hu JR, Florido R, Lipson EJ, et al. Cardiovascular toxicities associated with immune checkpoint inhibitors[J]. Cardiovasc Res, 2019, 115(5):854-868. DOI URL
[6]	Ball S, Ghosh RK, Wongsaengsak S, et al. Cardiovascular toxicities of immune checkpoint inhibitors:JACC review topic of the week[J]. J Am Coll Cardiol, 2019, 74(13):1714-1727. DOI URL
[7]	Wang DY, Salem JE, Cohen JV, et al. Fatal toxic effects associated with immune checkpoint inhibitors:a systematic review and meta-analysis[J]. JAMA Oncol, 2018, 4(12):1721-1728. DOI URL
[8]	马艳梅, 刘玉, 倪宏, 等. 免疫检查点抑制剂治疗相关不良反应的护理[J]. 护理研究, 2021, 35(16):2966-2970.
	Ma YM, Liu Y, Ni H, et al. Nursing care of adverse reactions related to immune checkpoint inhibitors treatment[J]. Chin Nurs Res, 2021, 35(16):2966-2970.
[9]	杨霈龙, 朱海燕. 帕博利珠单抗相关暴发性心肌炎一例[J]. 新医学, 2021, 52(9):717-720.
	Yang PL, Zhu HY. A case of fulminant myocarditis associated with pembrolizumab[J]. J New Med, 2021, 52(9):717-720.
[10]	Läubli H, Balmelli C, Bossard M, et al. Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma[J]. J Immunother Cancer, 2015, 3:11. DOI PMID
[11]	Bonaca MP, Olenchock BA, Salem JE, et al. Myocarditis in the setting of cancer therapeutics:proposed case definitions for emerging clinical syndromes in cardio-oncology[J]. Circulation, 2019, 140(2):80-91. PMID
[12]	江淑芬, 董畅, 刘莹, 等. 免疫检查点抑制剂相关心血管不良反应的机制、临床表现及管理[J]. 中华心血管病杂志, 2021, 49(4):410-414. PMID
	Jiang SF, Dong C, Liu Y, et al. Mechanism,clinical manifestation and management of adverse cardiac reactions related to immune checkpoint inhibitors[J]. Chin J Cardiol, 2021, 49(4):410-414. DOI PMID
[13]	施金存. 急性心肌炎患者院内心搏骤停的危险因素分析[D]. 温州: 温州医科大学, 2019.
	Shi JC. Risk factors analysis of cardiac arrest in patients with acute myocarditis[D]. Wenzhou: Wenzhou Medical University, 2019.
[14]	梁见弟, 叶继亮, 梁丽珍, 等. 60例慢性心力衰竭患者室性心律失常的特点及相关因素分析[J]. 中国医学创新, 2021, 18(12):151-155.
	Liang JD, Ye JL, Liang LZ, et al. Analysis of characteristics and related factors of ventricular arrhythmia in 60 patients with chronic heart failure[J]. Med Innov China, 2021, 18(12):151-155.
[15]	潘红, 黄琴红, 蔡英华, 等. 13例体外膜肺氧合治疗危重患者院内转运的护理[J]. 中华护理杂志, 2017, 52(5):561-563.
	Pan H, Huang QH, Cai YH, et al. Nursing care of 13 critically ill patients with extracorporeal membrane oxygenation for intra-hospital transfer[J]. Chin J Nurs, 2017, 52(5):561-563.
[16]	胡亚玲, 兰美娟, 汪春海, 等. 左心室辅助装置与体外膜肺氧合治疗1例心力衰竭患者的护理[J]. 中华护理杂志, 2021, 56(11):1707-1710. DOI
	Hu YL, Lan MJ, Wang CH, et al. Postoperative nursing care of a patient with heart failure treated by left ventricular assist device combined with central extracorporeal membrane oxygenation[J]. Chin J Nurs, 2021, 56(11):1707-1710.
[17]	柳红娟, 乔莹, 陈晗睿, 等. 2例暴发性心肌炎清醒患者使用体外膜肺氧合联合主动脉内球囊反搏治疗的护理[J]. 中华护理杂志, 2021, 56(12):1796-1799.
	Liu HJ, Qiao Y, Chen HR, et al. Nursing care of 2 patients with fulminant myocarditis with awake V-A extracorporeal membrane pulmonary oxygenation and intra-aortic balloon pump[J]. Chin J Nurs, 2021, 56(12):1796-1799.
[18]	中国心肺康复护理联盟专业委员会, 武汉市护理学会心血管专业委员会. 成人暴发性心肌炎护理策略专家共识[J]. 护理学杂志, 2021, 36(1):1-6.
	Chinese Federation of Cardiopulmonary Rehabilitation Nursing Professional Committee, Wuhan Nursing Association Cardiovascular Professional Committee. Expert consensus on nursing strategies for adult fulminant myocarditis[J]. J Nurs, 2021, 36(1):1-6.